Connect with us

coronavirus

Russia to submit Sputnik V vaccine for EU approval, says RDIF chief

SHARE:

Published

4 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Russia will submit a formal application to the European Union next month for approval of its Sputnik V coronavirus vaccine, the head of Russia’s sovereign wealth fund said today (14 January), write Andrew Osborn and Polina Ivanova.

Peer-reviewed results of the vaccine would be released shortly and would demonstrate its high efficacy, fund chief Kirill Dmitriev said in an interview at the Reuters Next conference.

He said Sputnik V would be produced in seven countries. He added that regulators in nine countries are expected to approve the vaccine for domestic use this month. It has already been approved in Argentina, Belarus, Serbia and elsewhere.

Russia, which has the world’s fourth-highest number of COVID-19 cases, plans to begin mass vaccinations next week.

For more coverage from the Reuters Next conference, click here.

To watch Reuters Next live, visit here.

Share this article:

Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending